Cite Filings / SPRY / 0002012383-26-001716

Feed Companies Filings Check

Sign in

SCHEDULE 13G/A

Statement of Beneficial Ownership

ARS Pharmaceuticals, Inc. Filed 2026-04-27 Acc 0002012383-26-001716

Documents 1

SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X02/primary_doc.xml

Around this filing

2026-05-15 SCHEDULE 13G/A Statement of Beneficial Ownership
2026-04-29 ARS Annual Report to Security Holders
2026-04-29 DEFA14A Proxy Materials
2026-04-29 DEF 14A Proxy Statement
2026-04-27 SCHEDULE 13G/A Statement of Beneficial Ownership
2026-03-31 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X02/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…